Xia Wu
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 9
-
- Inflammasome and immune disorders 7
- Extracellular vesicles in disease 6
- Co-authors
- Qiaohong Wang (4 shared papers)Yanbing Ding (1 shared paper)Yiming Li (1 shared paper)Yanjun Zhong (1 shared paper)Junke Long (1 shared paper)Wen J. Di (4 shared papers)Lifang Yang (8 shared papers)Yuping Gong (10 shared papers)
- Journals
- Scientific Reports (5 papers)PLoS ONE (3 papers)International Immunopharmacology (3 papers)Medicine (3 papers)Cancer Management and Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xia Wu
131 papers receiving 4.6k citations
Xia Wu's Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 742
- Epidemiology 790
- Infectious Diseases 412
- Sensory Systems 92
- General Dentistry 8
Countries citing papers authored by Xia Wu
This map shows the geographic impact of Xia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Wu more than expected).
Fields of papers citing papers by Xia Wu
This network shows the impact of papers produced by Xia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Wu. The network helps show where Xia Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis Hit paper breakdown → | 2019 | 830 |
| 2 | 2020 | 681 | |
| 3 | 2021 | 238 | |
| 4 | 2018 | 129 | |
| 5 | 2017 | 123 | |
| 6 | 2020 | 122 | |
| 7 | 2020 | 88 | |
| 8 | 2022 | 88 | |
| 9 | 2020 | 82 | |
| 10 | 2020 | 80 | |
| 11 | 2020 | 73 | |
| 12 | 2017 | 70 | |
| 13 | 2009 | 69 | |
| 14 | 2014 | 60 | |
| 15 | 2019 | 54 | |
| 16 | 2021 | 53 | |
| 17 | 2019 | 52 | |
| 18 | 2020 | 52 | |
| 19 | 2017 | 49 | |
| 20 | 2005 | 48 |
About Xia Wu
Xia Wu is a scholar working on Oncology, Molecular Biology, Hematology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 135 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Inflammasome and immune disorders (7 papers), Acute Myeloid Leukemia Research (6 papers), Extracellular vesicles in disease (6 papers), COVID-19 Clinical Research Studies (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Oncology (742 citations), Epidemiology (790 citations), Infectious Diseases (412 citations), Sensory Systems (92 citations) and General Dentistry (8 citations). Xia Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qiaohong Wang, Yanbing Ding, Yiming Li, Yanjun Zhong, Junke Long, Wen J. Di, Lifang Yang, Yuping Gong, Zhuan Zhou and Jinwu Peng. Their work appears in journals such as Scientific Reports, PLoS ONE, International Immunopharmacology, Medicine and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.